CandidateDrug4Cancer: An Open Molecular Graph Learning Benchmark on Drug Discovery for Cancer

03/02/2022

∙

Anti-cancer drug discoveries have been serendipitous, we sought to present the Open Molecular Graph Learning Benchmark, named CandidateDrug4Cancer, a challenging and realistic benchmark dataset to facilitate scalable, robust, and reproducible graph machine learning research for anti-cancer drug discovery. CandidateDrug4Cancer dataset encompasses multiple most-mentioned 29 targets for cancer, covering 54869 cancer-related drug molecules which are ranged from pre-clinical, clinical and FDA-approved. Besides building the datasets, we also perform benchmark experiments with effective Drug Target Interaction (DTI) prediction baselines using descriptors and expressive graph neural networks. Experimental results suggest that CandidateDrug4Cancer presents significant challenges for learning molecular graphs and targets in practical application, indicating opportunities for future researches on developing candidate drugs for treating cancers.

READ FULL TEXT

CandidateDrug4Cancer: An Open Molecular Graph Learning Benchmark on Drug Discovery for Cancer

Learn molecular representations from large-scale unlabeled molecules for drug discovery

MOOMIN: Deep Molecular Omics Network for Anti-Cancer Drug Combination Therapy

A Methodology for the Prediction of Drug Target Interaction using CDK Descriptors

DOCKSTRING: easy molecular docking yields better benchmarks for ligand design

Molecular docking and ADME/T analysis for identification of novel potential COX inhibitors of some isolated compounds from Clausena lansium for analgesic treatment

Conformal Prediction in Learning Under Privileged Information Paradigm with Applications in Drug Discovery

Scalable Graph Learning for Anti-Money Laundering: A First Look

CandidateDrug4Cancer: An Open Molecular Graph Learning Benchmark on Drug Discovery for Cancer

Related Research

Learn molecular representations from large-scale unlabeled molecules for drug discovery

MOOMIN: Deep Molecular Omics Network for Anti-Cancer Drug Combination Therapy

A Methodology for the Prediction of Drug Target Interaction using CDK Descriptors

DOCKSTRING: easy molecular docking yields better benchmarks for ligand design

Molecular docking and ADME/T analysis for identification of novel potential COX inhibitors of some isolated compounds from Clausena lansium for analgesic treatment

Conformal Prediction in Learning Under Privileged Information Paradigm with Applications in Drug Discovery

Scalable Graph Learning for Anti-Money Laundering: A First Look